Cargando…
Oncocytic Adrenocortical Neoplasm with Concomitant Papillary Thyroid Cancer
Adrenal oncocytoma (AO) is an extremely rare adrenocortical neoplasm and little is known about its malignant potential, secretory properties, and hereditary origin. We present the case of a benign AO with concomitant incidentally found papillary thyroid cancer (PTC) and review similar cases in the l...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786566/ https://www.ncbi.nlm.nih.gov/pubmed/29403439 http://dx.doi.org/10.3389/fendo.2017.00384 |
_version_ | 1783295803225276416 |
---|---|
author | Podetta, Michele Pusztaszeri, Marc Toso, Christian Procopiou, Michel Triponez, Frédéric Sadowski, Samira Mercedes |
author_facet | Podetta, Michele Pusztaszeri, Marc Toso, Christian Procopiou, Michel Triponez, Frédéric Sadowski, Samira Mercedes |
author_sort | Podetta, Michele |
collection | PubMed |
description | Adrenal oncocytoma (AO) is an extremely rare adrenocortical neoplasm and little is known about its malignant potential, secretory properties, and hereditary origin. We present the case of a benign AO with concomitant incidentally found papillary thyroid cancer (PTC) and review similar cases in the literature. Immunohistochemistry and next-generation sequencing (NGS) were performed. A 66-year-old women was incidentally found to have a large, androgen-secreting right adrenal mass. (18)F-Fluorodeoxyglucose positron emission tomography showed intense uptake (SUV(max) 88.7) of this mass and found a hypermetabolic right thyroid mass. Open adrenalectomy was performed for this highly suspicious adrenal mass. Histopathology revealed benign AO that was BRAF(V600E) negative, with low Ki-67, and no somatic mutation found on NGS. Thyroidectomy revealed invasive, BRAF(V600E)-positive PTC. At 6 months follow-up, androgen levels returned to normal, and no recurrence was seen on imaging. To our knowledge, this is the first report of an androgen-secreting AO with concomitant PTC. Possibly the simultaneous discovery of two independent neoplasms was observed. In conclusion, this case highlights that care should be given to exclude concomitant neoplasms. Long-term and regular imaging with biochemical follow-up is warranted, since the outcome and clinical behavior of AO remains uncertain. |
format | Online Article Text |
id | pubmed-5786566 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-57865662018-02-05 Oncocytic Adrenocortical Neoplasm with Concomitant Papillary Thyroid Cancer Podetta, Michele Pusztaszeri, Marc Toso, Christian Procopiou, Michel Triponez, Frédéric Sadowski, Samira Mercedes Front Endocrinol (Lausanne) Endocrinology Adrenal oncocytoma (AO) is an extremely rare adrenocortical neoplasm and little is known about its malignant potential, secretory properties, and hereditary origin. We present the case of a benign AO with concomitant incidentally found papillary thyroid cancer (PTC) and review similar cases in the literature. Immunohistochemistry and next-generation sequencing (NGS) were performed. A 66-year-old women was incidentally found to have a large, androgen-secreting right adrenal mass. (18)F-Fluorodeoxyglucose positron emission tomography showed intense uptake (SUV(max) 88.7) of this mass and found a hypermetabolic right thyroid mass. Open adrenalectomy was performed for this highly suspicious adrenal mass. Histopathology revealed benign AO that was BRAF(V600E) negative, with low Ki-67, and no somatic mutation found on NGS. Thyroidectomy revealed invasive, BRAF(V600E)-positive PTC. At 6 months follow-up, androgen levels returned to normal, and no recurrence was seen on imaging. To our knowledge, this is the first report of an androgen-secreting AO with concomitant PTC. Possibly the simultaneous discovery of two independent neoplasms was observed. In conclusion, this case highlights that care should be given to exclude concomitant neoplasms. Long-term and regular imaging with biochemical follow-up is warranted, since the outcome and clinical behavior of AO remains uncertain. Frontiers Media S.A. 2018-01-22 /pmc/articles/PMC5786566/ /pubmed/29403439 http://dx.doi.org/10.3389/fendo.2017.00384 Text en Copyright © 2018 Podetta, Pusztaszeri, Toso, Procopiou, Triponez and Sadowski. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Podetta, Michele Pusztaszeri, Marc Toso, Christian Procopiou, Michel Triponez, Frédéric Sadowski, Samira Mercedes Oncocytic Adrenocortical Neoplasm with Concomitant Papillary Thyroid Cancer |
title | Oncocytic Adrenocortical Neoplasm with Concomitant Papillary Thyroid Cancer |
title_full | Oncocytic Adrenocortical Neoplasm with Concomitant Papillary Thyroid Cancer |
title_fullStr | Oncocytic Adrenocortical Neoplasm with Concomitant Papillary Thyroid Cancer |
title_full_unstemmed | Oncocytic Adrenocortical Neoplasm with Concomitant Papillary Thyroid Cancer |
title_short | Oncocytic Adrenocortical Neoplasm with Concomitant Papillary Thyroid Cancer |
title_sort | oncocytic adrenocortical neoplasm with concomitant papillary thyroid cancer |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786566/ https://www.ncbi.nlm.nih.gov/pubmed/29403439 http://dx.doi.org/10.3389/fendo.2017.00384 |
work_keys_str_mv | AT podettamichele oncocyticadrenocorticalneoplasmwithconcomitantpapillarythyroidcancer AT pusztaszerimarc oncocyticadrenocorticalneoplasmwithconcomitantpapillarythyroidcancer AT tosochristian oncocyticadrenocorticalneoplasmwithconcomitantpapillarythyroidcancer AT procopioumichel oncocyticadrenocorticalneoplasmwithconcomitantpapillarythyroidcancer AT triponezfrederic oncocyticadrenocorticalneoplasmwithconcomitantpapillarythyroidcancer AT sadowskisamiramercedes oncocyticadrenocorticalneoplasmwithconcomitantpapillarythyroidcancer |